Adverse Events Related to Bevacizumab and the Management Principles in Non-small Cell Lung Cancer
Main Authors: | Gang CHENG, Li ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2010-06-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://www.lungca.org/index.php?journal=01&page=article&op=viewFile&path[]=10.3779%2Fj.issn.1009-3419.2010.06.001&path[]=1535 |
Similar Items
-
Application of Bevacizumab in Non-small Cell Lung Cancer
by: Ping XU, et al.
Published: (2017-04-01) -
Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer
with Brain Metastases
by: Liyan QU, et al.
Published: (2016-08-01) -
Advances in Bevacizumab Therapy of Primary Lung Cancer
by: Jun PEI, et al.
Published: (2009-02-01) -
Progress of Bevacizumab in the Front-line Treatment of Advanced Non-small Cell Lung Cancer
by: Bin AI, et al.
Published: (2020-07-01) -
Progress of Bevacizumab in Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
by: Yujie LIU, et al.
Published: (2019-02-01)